HomeInsightsDividend

Ortin Laboratories Ltd dividend

Ortin Laboratories Ltd dividend

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

2.7 K

stocks traded

Last Updated time: 22 Jul 9.00 AM

Image

Ortin Laboratories Ltd

NSE: ORTINLAB

DPS

--

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Ortin Laboratories Ltd is ₹ 0 as of 2023 .a1#The Dividend Payout of Ortin Laboratories Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#The Latest Trading Price of Ortin Laboratories Ltd is ₹ 18.94 as of 19 Jul 15:30 .a1#The Market Cap of Ortin Laboratories Ltd changed from ₹ 23.82 crore on March 2019 to ₹ 14.14 crore on March 2023 . This represents a CAGR of -9.90% over 5 years. a1#The Revenue of Ortin Laboratories Ltd changed from ₹ 2.62 crore to ₹ 0.31 crore over 8 quarters. This represents a CAGR of -65.60% a1#The EBITDA of Ortin Laboratories Ltd changed from ₹ 0.2 crore to ₹ -3.05 crore over 8 quarters. This represents a CAGR of NaN% a1#The Net Pr of Ortin Laboratories Ltd changed from ₹ -0.43 crore to ₹ -4.14 crore over 8 quarters. This represents a CAGR of 210.29% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Ortin Laboratories Ltd

Market Cap

15 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

5.5

DTE *

0.6

ROE *

-284.7

ROCE *

-142.5

Dividend Yield *

0

DPS *

0

Dividend Payout *

0

Ann.Dividend % *

0

* All values are consolidated

Last Updated time: 22 Jul 9.00 AM

* All values are consolidated

Last Updated time: 22 Jul 9.00 AM

×

Historical Dividend Payout of Ortin Laboratories Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Ortin Laboratories Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Ortin Laboratories Ltd

NSE: ORTINLAB

PRICE

18.94

-0.33 (-1.71%)

stock direction

Last updated : 19 Jul 15:30

SWOT Analysis Of Ortin Laboratories Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Ortin Laboratories Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Ortin Laboratories Ltd

Period
Mar '1924
Mar '2012
Mar '2126
Mar '2218
Mar '2314

* All values are a in crore

×

Historical Revenue of Ortin Laboratories Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Ortin Laboratories Ltd

Period
Jun '223
Sep '221
Dec '221
Mar '231
Jun '232
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical EBITDA of Ortin Laboratories Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Ortin Laboratories Ltd

Period
Jun '220
Sep '220
Dec '221
Mar '230
Jun '230
Sep '23-1
Dec '23-3
Mar '24-3

* All values are a in crore

×

Historical Net Profit of Ortin Laboratories Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Ortin Laboratories Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '230
Sep '23-1
Dec '23-3
Mar '24-4

* All values are a in crore

About Ortin Laboratories Ltd

About Ortin Laboratories Ltd

    Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. The Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India. The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations. The company offer anti arthritic drugs, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardio vascular drugs, anti diarroheal drugs, anti depressants, anti hypertensive, anti aids, anti tuberculosis drugs, gynaecological drugs, antibiotics, anti diabetic, antacids anti ulcer drugs, anti allergics, anti-cold, decongestants, antioxidents, vitamins, minerals, anti bacterial drugs, anti emetics, anti helmenthetics, nutritional supplements and protein, and appetizers. They also produce dental, ophthalmology, pediatric, diuretics, dermatology, psychiatry, and ENT drugs. The company constructed a Factory in a spacious area of 25,000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of tablets capsules syrups dry powders & ointments. During the year 2003-04, the company started their second division of products and marketing in few states. During the year 2006-07, the company got listed their shares in BSE- Indonext model, which provided a nation-wide trading platform for the investors of the company for their effective participation. They completed the up gradation of factory premises as per Revised Schedule M and started exporting their products to Asian, African countries and Middle East countries. During the year 2009-10, the company acquired the certification for the registration with National Drug Authority, Uganda wherein the company has got the eligibility to export their products to Uganda. During the year 2010-11, Vineet Laboratories Pvt Ltd, a private limited company engaged in the manufacturing of Fine Chemicals, Custom synthesis and specialized in making bulk drug intermediates for anti retrovirals and lipid lowering agents, etc was amalgamated with the company. Also, the company was allotted 6.18 acres of land in IDA, Buchinelli, Zaheerabad, Medak Dist., AP by APIIC. The company is planning to construct USFDA and European Standard Bulk Drug manufacturing facility. In 2010-11, M/s. Vineet Laboratories Private Limited (VLPL) was merged with the Company through the Scheme of Amalgamation, which was made effective from October 01, 2010. In terms of the said Scheme of Amalgamation, the Equity Shareholders of VLPL were entitled 17 Equity Shares of the Company for every 10 Equity Share held in Vineet Laboratories Private Limited. Thus, 1,22,40,000 fully paid-up equity shares of Rs. 10/- each of the Company were issued and allotted to the equity shareholders of Vineet Laboratories Private Limited in the same proportion as to their shareholding in Vineet Laboratories Private Limited. In 2017-18, the scheme of arrangement between the Company and Vineet Laboratories Limited for demerger of the API Intermediates Division of the Company as a going concern was implemented.

Ortin Laboratories Ltd News Hub

News

Ortin Laboratories schedules board meeting

Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 30 May ...

Read more

27 May 202416:33

News

Ortin Laboratories Ltd leads losers in 'B' group

Oricon Enterprises Ltd, Keynote Financial Services Ltd, PSP Projects Ltd and Sinclairs Hot...

Read more

12 Apr 202414:45

News

Ortin Laboratories EGM scheduled

Ortin Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company w...

Read more

24 Feb 202419:25

News

Ortin Laboratories to discuss results

Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 13 Febr...

Read more

08 Feb 202410:54

News

Ortin Laboratories EGM scheduled

Ortin Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company w...

Read more

20 Nov 202310:01

News

Ortin Laboratories announces board meeting date

Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

07 Nov 202316:59

FAQs for dividends of Ortin Laboratories Ltd

What is the current market price of Ortin Laboratories Ltd Ltd as of July 22, 2024?

The current market price of Ortin Laboratories Ltd Ltd stands at 18.9 per share.

What dividend did Ortin Laboratories Ltd declare in the last fiscal year?

In the last fiscal year, Ortin Laboratories Ltd declared a dividend totaling ₹0.0.

What is the most recent dividend declared by Ortin Laboratories Ltd?

Ortin Laboratories Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Ortin Laboratories Ltd declared dividends in the current fiscal year

Ortin Laboratories Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Ortin Laboratories Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Ortin Laboratories Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199